skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. WELL: Hi there, can you please provide which brokerages have a negative outlook on WELL? [WELL Health Technologies Corp.]
You can view 1 more answer this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi there, can you please provide which brokerages have a negative outlook on WELL? And why they're able to continually hold this stock down... consistently?

The positives are understood, so please help explain what is actually hated about this company and its stock? Nothing the company does seems to really matters, no real institutional support, sector they are in seems hated... for longer periods, etc

Which brokerages are the most negative on WELL, are reports available? Do they have valid reasoning to stay negative on WELL?

Are they still diluting existing shareholders? Is WELL's debt the issue?

Hoping to understand as much as possible about the markets negative reasoning to push the share price consistently lower on just about all news from the company!

Looking for all negative reasoning to help convince me to finally walk away from this disaster of a stock!!!

Looks as though its a trading stock rather then a long term investment, thoughts?

Thanks!
Asked by Hussein on March 20, 2026
5i Research Answer:

WELL has 13 analysts, all at BUY today. Targets range from $9.00 (Beacon) to $5.50 (CIBC). It did miss earnings estimates, and has missed three of the past eight quarters. There has been dilution. Share count was 41M in 2017 and is 255M now (most of this was for acquisitions). Revenue has gone from essentially zero to $1.5B (this year) in that period. Insiders own a good chunk and have not sold much. The accounting issue last year did not help sentiment, but it does seem to be more hated than loved. Many investors hated the CRH acquisition but it has been OK. It is acquisition-driven and some investors do not like this, preferring organic growth. We note EPS is expected to go from 6c last year to 37c next year. The stock remains very cheap but needs to execute on this expected growth. It has been a frustrating stock for sure. We think management is doing what is right for the company, long term. They have sold/privatized companies before and we are sure they are frustrated also. While "only" down 6% YTD it is down 52% in the past five years.